department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

OPKO HEALTH, INC. ($OPK) · pharmadog

PUBLIC COMPANY

$OPKOPKO HEALTH, INC.

Miami, FL, USupdated 1mo ago

SEC EDGAR ↗Yahoo Finance ↗

community read0 votes

pipeline

1

marketed

0

phase 3

0

catalysts ytd

0

approvals ytd

0

recalls ytd

0

Pipeline(1)

pipeline depth1 products

1Preclinical

Metabolic Dysfunction-Associated Steatohepatitis (MASH or…

Upcoming

no upcoming catalysts on record

Recent(90d)

nothing in the last 90 days

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view OPKO HEALTH, INC. jobs →

News

no news has mentioned this company yet

identifiers

ticker

$OPK

SEC CIK

0000944809

country

US

source

sec_tickers

top tags

mentioned in

0news items

entity-linker matched

$OPK

Active trials

phase2Phase 1/2 Study of OPK-88006 in Healthy and Presumed MASH Participantsnot yet recruitingn=30
phase2Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDIterminatedn=44
phase2Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Evaluation of CTAP101 Extended-release Capsules in Pediatric Participantsnot yet recruitingn=40
phase3Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidismterminatedn=2
phase3Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Childrencompletedn=224
phase2Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Childrencompletedn=48
phase2Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19completedn=171

Data sources

SEC EDGAR · openFDA

last refreshed 5m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 2

tagAdCom1 co-mentions · 1 sources
tagPMA Approval1 co-mentions · 1 sources

Insider activity

source: SEC Form 4

open-market buys + sells

Mar 20, 26BUYPAGANELLI JOHN A· director10,000 sh @ $1.14$11K↗

routine RSU / option mechanics (1)

Mar 18, 26grantUPPALURI SUBBARAO V · director50,000 sh